Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.24B 924M 802M 748M 687M 1.3B 87.9B 1.31B 8.82B 3.45B 43.94B 3.47B 3.39B 146B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.11B 1.05B 915M 853M 784M 1.48B 100B 1.5B 10.06B 3.93B 50.1B 3.96B 3.87B 166B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-0.44%
1 week+2.47%
Current month-0.65%
1 month-0.22%
3 months-9.15%
6 months+10.12%
Current year+5.06%
1 week 4.52
Extreme 4.52
4.64
1 month 4.36
Extreme 4.36
4.83
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.7
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Director/Board Member 58 2007-12-24
Chairman 56 2026-03-26
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Director

3,670,000 0.4719%
9/18/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%+2.47%-30.02%-44.13% 927M
-1.13%+1.13%-8.15%-3.96% 13.81B
-1.30%+1.34%-29.93%-50.51% 5.3B
-1.44%+5.41%+5.61%+9.42% 5.23B
+0.42%+0.30%+2.69%-31.78% 4.13B
-0.11%+2.24%-2.45%-2.80% 3.75B
-1.75%-2.12%-2.55%+5.14% 3.66B
-0.31%-0.44%-4.86%+15.27% 3.52B
-1.00%-0.69%-14.04%-22.43% 2.49B
-1.17%+2.19%-2.73%+51.63% 1.92B
Average -0.82%-0.28%-8.64%-7.41% 4.47B
Weighted average by Cap. -0.92%-0.23%-7.47%-7.60%

Financials

2024 2025
Net sales 3.83B 567M 492M 459M 421M 797M 53.9B 806M 5.41B 2.11B 26.95B 2.13B 2.08B 89.28B 3.05B 452M 392M 366M 336M 635M 42.96B 642M 4.31B 1.69B 21.47B 1.7B 1.66B 71.15B
Net income 33.62M 4.98M 4.32M 4.03M 3.7M 7.01M 474M 7.08M 47.54M 18.58M 237M 18.7M 18.29M 785M -104M -15.46M -13.42M -12.52M -11.5M -21.75M -1.47B -21.98M -148M -57.68M -735M -58.06M -56.78M -2.44B
Net Debt 1.4B 207M 180M 168M 154M 292M 19.73B 295M 1.98B 774M 9.86B 779M 762M 32.68B 875M 130M 113M 105M 96.36M 182M 12.32B 184M 1.24B 483M 6.16B 487M 476M 20.41B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-08-03 CN¥4.570 -0.44% 5,390,400
26-08-03 CN¥4.590 -0.22% 5,984,900
26-07-31 CN¥4.600 +0.88% 5,453,800
26-07-30 CN¥4.560 -0.44% 4,385,700
26-07-29 CN¥4.580 +0.88% 5,496,100

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock